Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
In Pills and Politics: Americans' Struggle for Affordable Medication, this book navigates the complex, often unsettling terrain of America's prescription drug crisis. It unpacks the forces behind soaring pharmaceutical prices, revealing a web of industry practices, political dependencies, and systemic barriers that place life-saving medication out of reach for many Americans.
With an in-depth look at both economic and ethical dimensions, the book explores how bipartisan reluctance for reform-rooted in campaign contributions and industry lobbying-perpetuates a status quo where drug costs are allowed to climb unchecked. While patients in other countries benefit from government-regulated pricing, Americans pay the world's highest prices, effectively subsidizing more affordable access abroad. Through this lens, the book uncovers a disturbing irony: Big Pharma's profits are disproportionately funded by U.S. patients, while American political leaders, bound by a dependency on industry donations, neglect the long-term health and financial security of their constituents.
The author also presents a way forward, drawing lessons from global models that balance innovation with accessibility. By championing reforms such as government-led price negotiations, expanded pathways for generics and biosimilars, and enforced transparency in pricing, the book provides a roadmap for creating a fairer, more affordable healthcare system in the U.S.
Ultimately, Pills and Politics is a call to action. For transformative change, all stakeholders-policymakers, healthcare providers, and patients-must work together. This book sheds light on the urgent need to confront the status quo and pursue a healthcare model where medication access is not a privilege but a right.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
In Pills and Politics: Americans' Struggle for Affordable Medication, this book navigates the complex, often unsettling terrain of America's prescription drug crisis. It unpacks the forces behind soaring pharmaceutical prices, revealing a web of industry practices, political dependencies, and systemic barriers that place life-saving medication out of reach for many Americans.
With an in-depth look at both economic and ethical dimensions, the book explores how bipartisan reluctance for reform-rooted in campaign contributions and industry lobbying-perpetuates a status quo where drug costs are allowed to climb unchecked. While patients in other countries benefit from government-regulated pricing, Americans pay the world's highest prices, effectively subsidizing more affordable access abroad. Through this lens, the book uncovers a disturbing irony: Big Pharma's profits are disproportionately funded by U.S. patients, while American political leaders, bound by a dependency on industry donations, neglect the long-term health and financial security of their constituents.
The author also presents a way forward, drawing lessons from global models that balance innovation with accessibility. By championing reforms such as government-led price negotiations, expanded pathways for generics and biosimilars, and enforced transparency in pricing, the book provides a roadmap for creating a fairer, more affordable healthcare system in the U.S.
Ultimately, Pills and Politics is a call to action. For transformative change, all stakeholders-policymakers, healthcare providers, and patients-must work together. This book sheds light on the urgent need to confront the status quo and pursue a healthcare model where medication access is not a privilege but a right.